Gilead s $7.8B Arcellx Acquisition: A Real-World Case Study | DeciBio posted on the topic | LinkedIn
Gilead s $7.8B Arcellx Acquisition: A Real-World Case Study | DeciBi…
2 views1 month ago
linkedin.com
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
Gilead to Buy German Biotech Tubulis for $3 Billion for Experime…
1 week ago
wsj.com
Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products
Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Prod…
2 months ago
wsj.com
Gilead to buy cancer biotech Tubulis in $5B deal
0:56
Gilead to buy cancer biotech Tubulis in $5B deal
1 week ago
MSNBloomberg
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
1 month ago
wsj.com
Guided by our long-standing commitment to the region and the communities we serve, we’re proud of the collective impact our teams make every day, which continue to help shape the Bay Area through scientific innovation, economic contribution and community partnerships. ​ In recognition of that leadership and influence, the San Francisco Business Times named Daniel O’Day, Chairman and CEO, to its Newsmakers 100 list. Gilead congratulates all the SFBT Newsmakers leaders who are shaping the Bay Area
0:51
Guided by our long-standing commitment to the region and the …
18.5K views1 month ago
FacebookGilead Sciences
Gilead Sciences on Reels
0:05
Gilead Sciences on Reels
132.8K viewsJul 3, 2019
FacebookGilead Sciences
Gilead rachète une biotech spécialisée dans le traitement du …
Sep 13, 2020
zonebourse.com
Gilead Sciences, Inc. Stock (GILD) - Quote Nasdaq- MarketScreener
Aug 18, 2020
marketscreener.com
Gilead Sciences: Global Health and Access
Sep 17, 2024
gilead.com
Gilead Sprints To A Profit-Taking Zone After Covid-Tied Beat
Nov 7, 2024
investors.com
3:46
Gilead CEO Daniel O'Day on acquisition of cancer drugmaker I…
Sep 14, 2020
CNBC
4:34
Gilead Sciences CEO Daniel O'Day on the collaboration with biotech f…
Jul 15, 2019
CNBCMeg Tirrell
1:03
At Gilead and Kite, we’re applying our combined expertise and learni…
24.9K views10 months ago
FacebookGilead Sciences
0:23
When it comes to #HIV prevention and care, trusted community spac…
53K views10 months ago
FacebookGilead Sciences
2:02
We’re focused on driving innovation in three therapeutic areas, and tha…
146.5K viewsMar 24, 2025
FacebookGilead Sciences
1:05
At Gilead, patients are at the heart of everything we do – and we’re focu…
47.4K viewsSep 12, 2024
FacebookGilead Sciences
0:16
Our Building 324 is no ordinary research building. It’s a space buil…
43.1K viewsApr 27, 2021
FacebookGilead Sciences
Fda Requires Gilead, Jnj, Novartis, Bristol Myers Squibb, 2Seven…
Jan 22, 2024
marketscreener.com
0:21
At Gilead, we innovate for impact. This commitment helps us drive s…
25.6K views1 year ago
FacebookGilead Sciences
2:21
At Gilead, we set and achieve bold ambitions in our fight against the …
31.1K viewsApr 10, 2025
FacebookGilead Sciences
0:28
These are Gilead scientists. They’re not just experts in oncology, virol…
93.8K views8 months ago
FacebookGilead Sciences
2:38
Gilead Sciences earnings top estimates, boosts full-year outlook
10.1K views8 months ago
YahooYahoo Finance Video
10:36
Gilead Sciences: What to know about the biopharma company wo…
May 7, 2020
Fox BusinessAnn Schmidt
Gilead Sciences: Innovation for growth - Technology and Operatio…
Dec 7, 2015
harvard.edu
0:58
At Gilead, we’ve spent decades focusing on #HIV and pushing the …
77.8K views11 months ago
FacebookGilead Sciences
$
Gilead CEO: “We are taking suggestions” on companies to buy
May 1, 2015
FortuneJen Wieczner
Why This Biotech Giant Is 'Underappreciated' Amid Novartis …
500 viewsAug 29, 2018
investors.com
0:46
Gilead and Kite are proud to partner with advocates taking back possib…
110K views8 months ago
FacebookGilead Sciences
1:35
This has been a year of transformative progress and mean…
630 viewsDec 18, 2024
FacebookGilead Sciences
See more videos
Static thumbnail place holder